Sorting Lithium-Ion Battery Electrode Materials Using Dielectrophoresis.

Lithium-ion batteries (LIBs) are common in everyday life and the demand for their raw materials is increasing. Additionally, spent LIBs should be recycled to achieve a circular economy and supply resources for new LIBs or other products. Especially the recycling of the active material of the electrodes is the focus of current research. Existing approaches for recycling (e.g., pyro-, hydrometallurgy, or flotation) still have their drawbacks, such as the loss of materials, generation of waste, or lack of selectivity. In this study, we test the behavior of commercially available LiFePO4 and two types of graphite microparticles in a dielectrophoretic high-throughput filter. Dielectrophoresis is a volume-dependent electrokinetic force that is commonly used in microfluidics but recently also for applications that focus on enhanced throughput. In our study, graphite particles show significantly higher trapping than LiFePO4 particles. The results indicate that nearly pure fractions of LiFePO4 can be obtained with this technique from a mixture with graphite.

Consequences of a Chronic Exposure of Cultured Brain Astrocytes to the Anti-Retroviral Drug Efavirenz and its Primary Metabolite 8-Hydroxy Efavirenz.

Efavirenz is a widely prescribed non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infections. To test for potential long-term consequences of efavirenz on brain cells, cultured primary astrocytes were incubated with this substance or with its primary metabolite 8-hydroxy efavirenz for up to 7 days. Both, efavirenz and 8-hydroxy efavirenz caused time- and concentration-dependent cell toxicity and stimulated in subtoxic concentrations the glycolytic flux (glucose consumption and lactate release) in astrocytes. As 8-hydroxy efavirenz was less toxic than efavirenz and stimulated glycolysis in lower concentrations we tested for a potential hydroxylation of efavirenz to 8-hydroxy efavirenz in astrocytes. Analysis of media and cell lysates by HPLC-UV and mass spectrometry revealed that after 3 days of incubation viable astrocytes had accumulated about 17 and 7 % of the applied efavirenz and 8-hydroxy efavirenz, respectively. However, in cultures treated with efavirenz neither 8-hydroxy efavirenz nor any other known metabolite of efavirenz was detectable. These data demonstrate that cultured rat astrocytes efficiently accumulate, but not metabolize, efavirenz and 8-hydroxy efavirenz and that the observed chronic stimulation of glycolysis is mediated by both efavirenz and 8-hydroxy efavirenz.